ET Resource

Home > Topic Index > ARV Treatment

Antiretroviral Therapy(119 Matches)

Antiretroviral Guidelines (5) CD-ROMs (1) Charts and Tables (8) Charts, Tables & Posters (3) Clinical Manual Chapter (13) Curricula (1) Fact Sheets (1) HIV Meds Quarterly Article (49) Manuals (2) Newsletters (1) Online Training (2) Patient Information (4) Pocket Guides (8) Primary Care Guidelines (1) Program Information (1)

Antiretroviral Guidelines

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Date: January 10, 2011
Source: Department of Health and Human Services
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
Date: August 16, 2010
Source: Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children and Department of Health and Human Services
Antiretroviral Treatment of Adult HIV Infection: 2010 Recommendations of the International AIDS Society-USA Panel
Date: July 21, 2010
Source: International AIDS Society-USA
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
Date: May 24, 2010
Source: Department of Health and Human Services
Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel
Date: July 15, 2008
Source: International AIDS Society-USA

CD-ROMs

HIV/AIDS Clinician Toolkit
Date: August 2010
Source: AETC National Resource Center

Charts and Tables

Medication Teaching Guide
Date: April 2010
Source: Northwest AETC
Dosage Adjustments for ARV-ARV Drug Interactions
Date: July 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Dosing of Antiretroviral Drugs in Adults with Renal Insufficiency and Hemodialysis
Date: July 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Adverse Effects of Antiretroviral Drugs
Date: July 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Helpful HIV Medication Tables for Pharmacists
Date: 2009
Source: New York/New Jersey AETC
Etravirine: ARV Interactions
Date: May 2008
Source: AETC National Resource Center
FDA-Approved Antiretrovirals for the Treatment of HIV Infection
Date: April 2008
Source: Northwest AETC
Database of Antiretroviral Drug Interactions
Source: UCSF Center for HIV Information

Charts, Tables & Posters

U.S.-Mexico Antiretroviral Drug Chart
Date: August 2010
Source: U.S./Mexico Border AETC Steering Team (UMBAST); Texas/Oklahoma AETC; Mountain Plains AETC; Pacific AETC and AETC National Resource Center
Dosing for Ritonavir-Boosted Protease Inhibitors
Date: July 2010
Source: AETC National Resource Center and UCSF Center for HIV Information
A Pharmacist's Guide to Antiretroviral Medications
Date: February 2009
Source: Mountain Plains AETC

Clinical Manual Chapter

Curricula

Topics in the Nursing Care of People Living with HIV/AIDS
Date: September 2009
Source: New York/New Jersey AETC and Rutgers, The State University of New Jersey, College of Nursing local performance site

Fact Sheets

HIV Antiretroviral (ARV) Treatment: Guidelines and Strategies for Correctional Health Care Providers
Date: March 2010
Source: Pacific AETC and San Francisco Local Performance Site

HIV Meds Quarterly Article

HIV Meds Quarterly
Date: September 2010
Source: AETC National Resource Center and UCSF Center for HIV Information
HIV Meds Quarterly
Date: September 2010
Source: AETC National Resource Center and UCSF Center for HIV Information
Efavirenz and Levonorgestrel
Date: October 2009
Source: AETC National Resource Center
HIV Meds Quarterly
Date: October 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Kaletra Dosage Adjustment for Patients on Efavirenz or Nevirapine
Date: October 2009
Source: AETC National Resource Center
Once-Daily Raltegravir
Date: October 2009
Source: AETC National Resource Center
Updates to the Database of ARV Drug Interactions
Date: October 2009
Source: AETC National Resource Center
Atazanavir and Lopinavir/Ritonavir in Hemodialysis
Date: October 2009
Source: AETC National Resource Center
Lopinavir/ritonavir and Buprenorphine
Date: October 2009
Source: AETC National Resource Center
Updates to the Database of ARV Drug Interactions
Date: October 2009
Source: AETC National Resource Center
Vicriviroc in Treatment-Experienced Patients
Date: October 2009
Source: AETC National Resource Center
HIV Meds Quarterly
Date: October 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Updates to the Database of ARV Drug Interactions
Date: October 2009
Source: AETC National Resource Center
Novel Pharmacokinetic Booster Cobicistat (GS-9350)
Date: October 2009
Source: AETC National Resource Center
Efficacy and Safety of Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir (Quad Pill) in Initial Therapy
Date: October 2009
Source: AETC National Resource Center
S/GSK 572 in Initial Therapy: Interim Results of SPRING-1
Date: October 2009
Source: AETC National Resource Center
Rilpivirine (TMC278) in Initial Therapy
Date: October 2009
Source: AETC National Resource Center
Rosuvastatin Levels Increased by Ritonavir-Boosted Darunavir
Date: October 2009
Source: AETC National Resource Center
Regimen Simplification: Atazanavir vs Atazanavir/Ritonavir
Date: August 2009
Source: AETC National Resource Center
HIV Meds Quarterly
Date: August 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Investigational Integrase Inhibitor Shows Potent Activity in Early Studies
Date: August 2009
Source: AETC National Resource Center
Atazanavir/Ritonavir in Pregnancy
Date: August 2009
Source: AETC National Resource Center
Updates to the Database of ARV Drug Interactions
Date: August 2009
Source: AETC National Resource Center
New Pharmacokinetic Booster on the Horizon
Date: May 2009
Source: AETC National Resource Center
Antipsychotics and Sudden Cardiac Death
Date: May 2009
Source: AETC National Resource Center
Rosiglitazone and Heart Disease
Date: May 2009
Source: AETC National Resource Center
HIV Meds Quarterly
Date: May 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Updates to the Database of ARV Drug Interactions
Date: May 2009
Source: AETC National Resource Center
Abacavir and Myocardial Infarction Risk: Additional Data
Date: May 2009
Source: AETC National Resource Center
Raltegravir Substitution for Lopinavir/Ritonavir (SWITCHMRK Study)
Date: May 2009
Source: AETC National Resource Center
Interleukin-2: No Clinical Benefit
Date: May 2009
Source: AETC National Resource Center
HIV Meds Quarterly
Date: February 2009
Source: AETC National Resource Center and UCSF Center for HIV Information
Darunavir Approved for Use with Boosted Ritonavir as Preferred PI, Pediatric Dosing
Date: February 2009
Source: AETC National Resource Center
Abacavir and Risk of Myocardial Infarction: The SMART Study
Date: October 2008
Source: AETC National Resource Center
Pregabalin for Neuropathic Pain: Not More Effective Than Placebo
Date: October 2008
Source: AETC National Resource Center
HIV Meds Quarterly
Date: October 2008
Source: AETC National Resource Center and UCSF Center for HIV Information
Atazanavir: Interactions with Efavirenz, Nevirapine, and Oral Hormonal Contraceptives
Date: October 2008
Source: AETC National Resource Center
Abacavir/Lamivudine: Higher Rates of Virologic Failure in ARV-Naive Patients with HIV RNA ≥100,000 copies/mL Compared with Tenofovir/Emtricitabine
Date: October 2008
Source: AETC National Resource Center
Abacavir and Didanosine Associated with Increased Risk of Myocardial Infarction
Date: August 2008
Source: AETC National Resource Center
HIV Meds Quarterly
Date: August 2008
Source: AETC National Resource Center and UCSF Center for HIV Information
Rifampin and "Super-Boosted" Protease Inhibitors
Date: August 2008
Source: AETC National Resource Center
Rosuvastatin with Lopinavir/Ritonavir and Tipranavir
Date: August 2008
Source: AETC National Resource Center
Testing for Chemokine Coreceptor Tropism
Date: August 2008
Source: AETC National Resource Center
Concurrent Use of Atazanavir and Acid-Lowering Medications
Date: May 2008
Source: AETC National Resource Center
HLA-B*5701 Screening for Abacavir Hypersensitivity
Date: May 2008
Source: AETC National Resource Center
Efficacy: Atazanavir/Ritonavir vs Lopinavir/Ritonavir
Date: May 2008
Source: AETC National Resource Center
HIV Meds Quarterly
Date: May 2008
Source: AETC National Resource Center and UCSF Center for HIV Information
Atazanavir Use in Severe Renal Impairment and Renal Failure
Date: May 2008
Source: AETC National Resource Center
Raltegravir Substitution for Enfuvirtide
Date: May 2008
Source: AETC National Resource Center

Manuals

HIV Manual
Date: May 2010
Source: Beth Israel Deaconess Medical Center; Healthcare Associates and New England AETC
A Sourcebook for the Primary Care Provider
Date: 2009
Source: Mountain Plains AETC

Newsletters

mental health AIDS
Source: New England AETC

Online Training

HIV Web Study
Date: 2008
Source: Northwest AETC
Treating Adolescents with HIV: Tools for Building Skills in Cultural Competence, Clinical Care and Support
Date: 2007
Source: AETC National Resource Center; Adolescent AIDS Program, Children's Hospital at Montefiore and John Snow, Inc.

Patient Information

HIV and Its Treatment: What You Should Know
Date: December 2009
Source: AIDSinfo/infoSIDA
What Women Need to Know: The HIV Treatment Guidelines for Pregnant Women
Date: 2009
Source: François Xavier Bagnoud Center at UMDNJ
Making MEDS Work for You
Date: 2005
Source: François Xavier Bagnoud Center at UMDNJ
Antiretroviral Drug Fact Sheets
Source: Mountain Plains AETC and AIDS InfoNet

Pocket Guides

Antiretroviral Agents - Pediatric Edition
Date: May 2010
Source: Florida/Caribbean AETC
Antiretroviral Therapy in Adults and Adolescents
Date: May 2010
Source: Florida/Caribbean AETC
Opioid Pain and Addiction Management Medications -- Drug Interactions with HIV Antiretrovirals
Date: February 2010
Source: New York/New Jersey AETC
Recreational Drugs and HIV Antivirals: A Guide to Interactions for Clinicians
Date: November 2009
Source: New York/New Jersey AETC
Guidelines for Use of HIV Antiretroviral Therapy in Pregnancy (Pocket card)
Date: February 2008
Source: François Xavier Bagnoud Center at UMDNJ
Psychiatric Medications and HIV Antiretrovirals: A Guide to Interactions for Clinicians
Date: 2008
Source: New York/New Jersey AETC
Pocket Guide to Adult HIV/AIDS Treatment
Date: January 2006
Source: Pennsylvania/MidAtlantic AETC
HIV Medications Available in Liquid, IV, Capsule, and Tablet
Date: September 29, 2005
Source: Department of Health and Human Services

Primary Care Guidelines

Adapting Your Practice: Treatment and Recommendations for Homeless Patients with HIV/AIDS
Date: 2008
Source: Health Resources and Services Administration and National Health Care for the Homeless Clinicians' Network

Program Information

AETC Resources for HRSA HAB Clinical Performance Indicators
Date: December 2010
Source: Health Resources and Services Administration

Materials Usage Guidelines

We ask that those wishing to use the materials found on the AETC NRC website honor the following guidelines:

Slide sets and other materials that appear on the AETC NRC website are intended for public use, unless otherwise noted.
You may use or present a slide set or other material in its entirety if you credit the author and source of the material.
Similarly, you may incorporate selected slides or resources from the AETC NRC website into another public presentation if you credit the author and/or source of the materials.
If you use materials from the AETC NRC website in preparing other presentations or materials, please Include an appropriate reference citation.
Do not publish or post materials found on the AETC NRC site without permission from their creators or copyright holders.
For examples of appropriate citation, see our Using and Adapting Slides frequently asked questions.

Copyright 2011, the AIDS Education & Training Centers National Resource Center, unless otherwise noted. All rights reserved. Email webmaster@aidsetc.org with questions, comments, or problems. See disclaimer for usage guidelines.